Author Correction: Targeting myeloid derived suppressor cells reverts immune suppression and sensitizes BRAF-mutant papillary thyroid cancer to MAPK inhibitors

Peitao Zhang, Haixia Guan, Shukai Yuan, Huili Cheng, Jian Zheng, Zhenlei Zhang, Yifan Liu, Yang Yu, Zhaowei Meng, Xiangqian Zheng and Li Zhao ()
Additional contact information
Peitao Zhang: Tianjin Medical University
Haixia Guan: Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences
Shukai Yuan: Tianjin Medical University
Huili Cheng: Tianjin Medical University
Jian Zheng: Tianjin Medical University
Zhenlei Zhang: Tianjin Medical University
Yifan Liu: Tianjin Medical University
Yang Yu: Tianjin Medical University Cancer Institute and Hospital
Zhaowei Meng: Tianjin Medical University General Hospital
Xiangqian Zheng: Tianjin Medical University Cancer Institute and Hospital
Li Zhao: Tianjin Medical University

Nature Communications, 2022, vol. 13, issue 1, 1-1

Date: 2022
References: Add references at CitEc
Citations: View citations in EconPapers (1)

Downloads: (external link)
https://www.nature.com/articles/s41467-022-34545-6 Abstract (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:natcom:v:13:y:2022:i:1:d:10.1038_s41467-022-34545-6

Ordering information: This journal article can be ordered from
https://www.nature.com/ncomms/

DOI: 10.1038/s41467-022-34545-6

Access Statistics for this article

Nature Communications is currently edited by Nathalie Le Bot, Enda Bergin and Fiona Gillespie

More articles in Nature Communications from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().